Microcap Ledger

Tickers · $CABR

Caring Brands, Inc. $CABR

By Microcap Ledger desk · CIK 0002020737

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
Nasdaq Capital Market
Sector
Perfumes, Cosmetics & Other Toilet Preparations
Headquarters
Fort Pierce, FL
Fiscal year end
December 31
Shares outstanding
10,368,226 [10-Q 2026-08-13]
as of 2026-08-13

Sources: [10-K 2026-03-31]

What the company doesAI summary of filing

Caring Brands is a wellness consumer products company that develops and sells over-the-counter and cosmetic products targeting various health conditions. Its product pipeline includes treatments for hair loss, eczema, psoriasis, vitiligo, jellyfish sting protection, and women's sexual wellness, which are developed using controlled clinical trials and patent protection. The company is pre-revenue to minimal-revenue stage, having reported nominal revenues and losses of $6.3 million for the year ended December 31, 2025, and nominal revenues with a net loss of $1.5 million for 2024. Products are commercialized through a combination of direct e-commerce channels (including Amazon) and licensing agreements with manufacturers in India and Japan. [10-K 2026-03-31]

Segments: Photocil (vitiligo and psoriasis treatment), Hair Enzyme Booster/JW-700 (minoxidil efficacy enhancer), CB-101 (eczema treatment), NoStingz (jellyfish sting protective sunscreen)

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
6 months to Jun 2026—−$2.65M −$1.01M$1.82M[10-Q 2026-08-13]
FY ended Dec 2025$4.2K−$6.28M −$1.69M$2.19M[S-1 2026-05-06]
FY ended Dec 2024—−$1.52M —$469.0K[S-1 2026-05-06]
Quarterly cash burn
−$506.9K
Cash runway Estimate
~10.8 months

Estimate: cash at the end of the period (6 months to Jun 2026) divided by the average monthly operating cash outflow over that period. Ignores any cash raised or spent since, and any financing.

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2025-11-1413,736,925[10-Q 2025-11-14]
2026-03-3012,341,506[10-K 2026-03-31]
2026-05-119,091,506[10-Q 2026-05-12]
2026-08-1310,368,226[10-Q 2026-08-13]
Shelf registration
S-1 filed 2026-05-06; declared effective 2026-05-14 [S-1 2026-05-06]

Listing status

Current status: 2 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-07-17. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

DateEventDetailsDeadlineFiling
2026-07-178-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2026-07-17]
2026-04-108-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2026-04-10]

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
DateInsiderTypeSharesPriceFiling
2026-07-23John Brianother150,000$1.00[4 2026-07-28]
2026-03-27Wilson Glynnother1,500,000$0.50[4 2026-03-27]
2026-03-27John Brianother1,250,000$1.00[4 2026-03-27]

Catalysts and calendar

Facts as of . Small caps move fast; check the latest filings.